• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

    Ascendia Pharmaceuticals Poised for Expansion

    Bora Pharmaceuticals Adds Roller Compaction Capabilities

    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

    AGC Biologics Appoints Jun Takami GM of Chiba Site
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Ascendia Pharmaceuticals Poised for Expansion

    Bora Pharmaceuticals Adds Roller Compaction Capabilities

    Alkermes, Merck Enter Clinical Trial and Supply Agreement

    Sterling Pharma Solutions Acquires ADC Biotechnology

    Moderna, Catalent Enter Long-Term Strategic Vax Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success

    Enteris BioPharma: Custom Solutions – From Bench to Market

    The Benefits of Outsourcing Cold Storage
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

    Ascendia Pharmaceuticals Poised for Expansion

    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

    Agilex Biolabs Acquires TetraQ for APAC Expansion Plans

    Alkermes, Merck Enter Clinical Trial and Supply Agreement
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market

    Metrics Contract Services Completes Russian Regulatory Inspection
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Syngene

    PCI Pharma Services

    Aphena Pharma Solutions

    Adare Pharma Solutions

    Quotient Sciences
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Emergent BioSolutions

    Quotient Sciences

    Baxter BioPharma Solutions

    Almac Group

    Aphena Pharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    WuXi’s PDS Division Merges with STA

    Tie-up creates a full service CDMO

    WuXi’s PDS Division Merges with STA
    Related CONTENT
    • WuXi AppTec
    • Vetio Animal Health
    • STA, TESARO Ink Five-Year Supply Pact
    • Eurofins to Acquire Amatsigroup for $150M
    • Idifarma Approved for EU-GMP Commercial Capsule Mfg.
    07.31.17
    STA Pharmaceutical, a WuXi AppTec group company, has merged with WuXi AppTec’s Pharmaceutical Development Services (PDS) division.

    The PDS division offers pre-formulation development, formulation development, as well as clinical trial material (CTM) manufacturing, packaging and labeling of oral solid dosage forms including tablets, capsules, sachets and oral solutions/suspensions. PDS also established various enabling technology platforms for low soluble drugs including spray dried dispersion, hot melt extrusion, micro or nano suspension and liquid-filled hard gelatin capsules. Two commercial-scale drug product manufacturing facilities currently under construction are expected to become operational later this year and early next year, respectively.

    STA Pharmaceutical, after this merger, will provide fully integrated small molecule active pharmaceutical ingredient (API) and drug product solutions to global clients, resulting in a seamless chemistry, manufacturing and control  (CMC) working process. The merger enables STA to advance new chemical entities from pre-clinical stage to new drug application (NDA) and to market faster and more efficiently for pharma and biotech customers.

    This development enhanced STA’s end-to-end capabilities as a full-service contract development and manufacturing organization (CDMO), and it anticipates rapid growth in clinical trial supply, especially amongst early stage targets, where there are practical benefits in working with one CDMO.

    “STA has been growing rapidly over the last few years,” said Minzhang Chen, chief executive officer, STA Pharmaceutical. “It was a natural progression for the company to add drug product to our API platform in which we are globally renowned.”

    Ge Li, chairman and chief executive officer, WuXi AppTec, said, “The merging of the PDS division into STA is an important step for WuXi. Providing API and drug product services under one STA entity further strengthens WuXi’s comprehensive CDMO offering. Ultimately, our platforms advance vital new medicines through the development cycle faster, allowing our global partners to discover and develop better medicines for patients.”
    Related Searches
    • chief executive officer
    • patients
    • Pre-Formulation
    • Pharma
    Suggested For You
    WuXi AppTec WuXi AppTec
    Vetio Animal Health Vetio Animal Health
    STA, TESARO Ink Five-Year Supply Pact STA, TESARO Ink Five-Year Supply Pact
    Eurofins to Acquire Amatsigroup for $150M Eurofins to Acquire Amatsigroup for $150M
    Idifarma Approved for EU-GMP Commercial Capsule Mfg. Idifarma Approved for EU-GMP Commercial Capsule Mfg.
    Will Immunotherapy Knock Out Cancer? Will Immunotherapy Knock Out Cancer?
    CoreRx, Aimmune Unveil Joint Expansion CoreRx, Aimmune Unveil Joint Expansion
    Newsmakers: Lee Karras Newsmakers: Lee Karras
    UPM Celebrates 100-Years of Mfg. at Tennessee Site UPM Celebrates 100-Years of Mfg. at Tennessee Site
    Thermo Fisher Buys Patheon for $7.2B Thermo Fisher Buys Patheon for $7.2B
    Patheon Completes NC Sterile Expansion  Patheon Completes NC Sterile Expansion
    Recipharm Opens GMP Suite for Clinical Trial Materials Recipharm Opens GMP Suite for Clinical Trial Materials
    Newsmakers: Peter Soelkner Newsmakers: Peter Soelkner
    DCAT Week DCAT Week '17 Q&A: API Market Trends
    Solubility Enhancement: Novel Approaches to Rational Formulation Choice Solubility Enhancement: Novel Approaches to Rational Formulation Choice

    Related Breaking News

    • Breaking News | cGMP Manufacture | Formulation Development | Industry News
      Piramal Pharma Solutions, Plus Therapeutics Ink MSA 


      Piramal Pharma Solutions, Plus Therapeutics Ink MSA 


      Piramal to perform services related to the development, manufacture, and supply of Plus Therapeutics’ RNL-Liposome Intermediate Drug Product.
      Kristin Brooks 03.24.21

    • Breaking News | Formulation Development | Industry News
      Cybin to Leverage Catalent’s Zydis for Psychiatric Drug

      Cybin to Leverage Catalent’s Zydis for Psychiatric Drug

      To apply Zydis orally disintegrating tablet (ODT) technology for delivery of Cybin’s potential therapy for treatment-resistant psychiatric disorders.
      Kristin Brooks 03.22.21

    • Breaking News | Formulation Development | Industry News
      Rentschler, Leukocare Extend Service Offering with U.S. Site

      Rentschler, Leukocare Extend Service Offering with U.S. Site

      Opens Leukocare’s U.S. development labs and offices at Rentschler's facility in the Greater Boston area, where the two companies will work together.
      Kristin Brooks 03.22.21


    • APIs | Breaking News | Formulation Development | Industry News
      Tris Pharma, Athena Bioscience Enter Exclusive License Agreement

      Tris Pharma, Athena Bioscience Enter Exclusive License Agreement

      Athena gains exclusive rights to commercialize a long-acting antihypertensive product developed using Tris' proprietary technology.
      Kristin Brooks 02.22.21

    • Breaking News | Formulation Development | Industry News | Promotions & Moves
      Novartis Vet Joins CDMO Sai Life Sciences

      Novartis Vet Joins CDMO Sai Life Sciences

      Mahavir Prashad named as vice president of early phase process development.
      Tim Wright, Editor, Contract Pharma 02.17.21

    • APIs | Breaking News | Drug Development | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
      Lonza Expands Solid Small Molecule Services

      Lonza Expands Solid Small Molecule Services

      To encompass all aspects of solid form screening and characterization of small molecule APIs.
      Kristin Brooks 02.16.21


    • Breaking News | Formulation Development | Industry News | Methods Development
      Adare Pharma Solutions Opens New Small-Scale Lab

      Adare Pharma Solutions Opens New Small-Scale Lab

      Vandalia, OH lab offers customizable, flexible systems designed to expedite formulation and process development services.
      Kristin Brooks 01.26.21

    • Breaking News | Formulation Development | Industry News
      Hovione Launches ASD-HIPROS

      Hovione Launches ASD-HIPROS

      Advanced tool designed to identify optimal and commercially viable Amorphous Solid Dispersions formulation by Spray Drying.
      Contract Pharma Staff 01.12.21

    • Biologics, Proteins, Vaccines | Breaking News | Fill/Finish | Formulation Development | Industry News
      Moderna, Recipharm Enter COVID-19 Vax Mfg. Agreement

      Moderna, Recipharm Enter COVID-19 Vax Mfg. Agreement

      Recipharm to provide aseptic drug product manufacturing and fill-finish of Moderna’s COVID-19 vaccine outside of the U.S.
      Contract Pharma Staff 01.04.21


    • Breaking News | Drug Development | Formulation Development | Industry News
      Vectura, Kinaset Partner to Develop Asthma Treatment

      Vectura, Kinaset Partner to Develop Asthma Treatment

      Licenses VR588 to Kinaset, Vectura will provide formulation development services to support Phase I studies and ultimately commercialization.
      Contract Pharma Staff 11.30.20

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Formulation Development | Industry News
      Lonza Expands Development, Mfg. Capabilities at Bend Site

      Lonza Expands Development, Mfg. Capabilities at Bend Site

      Investment will add 11 new suites for particle engineering and drug product capacity to improve program lead times.
      Contract Pharma Staff 11.30.20

    • Analytical Services | Breaking News | Formulation Development | Industry News | Laboratory Testing
      Cambrex Completes Edinburgh Expansion

      Cambrex Completes Edinburgh Expansion

      Doubles the facility's footprint to 15,000 sq.-ft., existing lab space is refurbished, and an additional 3,500 sq.-ft. of lab space added.
      Contract Pharma Staff 10.12.20


    • Breaking News | cGMP Manufacture | Formulation Development | Industry News | Scale-up/Technology Transfer
      Catalent Launches OneXpress Solution

      Catalent Launches OneXpress Solution

      Aims to accelerate a program’s transition from early-phase development to commercial-ready manufacturing for oral dosage products.
      Contract Pharma Staff 10.01.20

    • Breaking News | cGMP Manufacture | Formulation Development | Industry News | Process Development
      Thomas Lee Partners, Frazier Healthcare Acquires Adare Pharmaceuticals

      Thomas Lee Partners, Frazier Healthcare Acquires Adare Pharmaceuticals

      Includes Adare’s CDMO, pharmaceutical technology and microbiome businesses; will rebrand as Adare Pharma Solutions.
      Contract Pharma Staff 09.30.20

    • APIs | Breaking News | cGMP Manufacture | Chemistry | Drug Development | Excipients | Formulation Development | Industry News
      Piramal to Deliver Integrated Services to Epirium

      Piramal to Deliver Integrated Services to Epirium

      Includes formulation development, supply of APIs and intermediates, chemistry development and manufacturing, and solid oral dosage form drug product.
      Contract Pharma Staff 08.27.20

    Trending
    • Sterling Pharma Solutions Acquires ADC Biotechnology
    • Sanofi To Build New $700M Flu Vaccine Facility In Canada
    • Alkermes, Merck Enter Clinical Trial And Supply Agreement
    • Ascendia Pharmaceuticals Poised For Expansion
    • Frontage Expands Capabilities At Its Clinical Site In Secaucus, NJ
    Breaking News
    • Bora Pharmaceuticals Adds Roller Compaction Capabilities
    • Ascendia Pharmaceuticals Poised for Expansion
    • Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    • Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    • AGC Biologics Appoints Jun Takami GM of Chiba Site
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health
    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status
    Nutritional Complex Evidenced to Reduce Preterm Birth
    Coatings World

    Latest Breaking News From Coatings World

    Barentz Expands Canadian CASE Team
    Shepherd Color Company Opens Sales Office in China
    Chromaflo Technologies Awarded Gold Status CSR Rating by EcoVadis in EMEA
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CMS Establishes New Payment for Pelvalon’s Eclipse System
    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    Resonetics Leases New Manufacturing Space in Costa Rica
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    Ascendia Pharmaceuticals Poised for Expansion
    Bora Pharmaceuticals Adds Roller Compaction Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Revlon Unveils New Fragrances Featuring Megan Thee Stallion & Sofia Carson
    Henkel Management Board Welcomes Wolfgang König
    Mielle Organics Gets a Major Investment
    Happi

    Latest Breaking News From Happi

    Nature’s Beauty Debuts Vegan Natural Body Care at Walgreens
    Estée Lauder Expands 'Beautiful' Fagrance Collection
    Mushrooms Are Key Ingredients in Beauty & Wellness
    Ink World

    Latest Breaking News From Ink World

    SE-DA Invests in Kornit Presto S
    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Iron Oxide Pigments Market to Register 4.7% CAGR from 2021 to 2028: GVR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Dantex elevates Joseph Sanchez to digital business development manager
    Mactac's Kevin Clunie joins TLMI panel
    MacDermid announces two new global sales roles
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Precision Textiles Offers Biodegradable Medical Fabric
    Northshore Launches Megamax Briefs in New Colors
    Essity Acquires Distribution Rights to Sorbact in Australia and New Zealand
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    Google Executive Joins SeaSpine's Board of Directors
    HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Tive Multi-sensor Tracker Solo 5G Relies on Sensirion SHT33
    VTT in 2020: Successful Year Despite Globally Challenging Times
    Lux Research: 3D Printing Market to Reach $51 Billion in 2030

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login